This inventor holds 7 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Kringle Pharma Inc., Osaka University, Other. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Minoh, JP (2011 - 2012)
- Mino, JP (2010 - 2013)
- Osaka, JP (2019 - 2020)
Company Filing History:

Years Active: 2010-2020
Title: Kazuhiro Fukuta: Innovator in Neurological Treatments
Introduction
Kazuhiro Fukuta is a prominent inventor based in Mino, Japan. He has made significant contributions to the field of medical innovations, particularly in the treatment of neurological disorders. With a total of 7 patents to his name, Fukuta's work is recognized for its potential impact on healthcare.
Latest Patents
One of Fukuta's latest patents is a hepatocyte growth factor (HGF) preparation designed for the treatment of neurological disorders. This invention provides an HGF preparation in the form of an injection that is highly safe for central nerves and stable for various administration methods. The preparation contains an HGF protein as the active ingredient, along with lactose, glycine, sodium chloride, a pH buffering agent, and a surfactant as additional ingredients. This innovative approach aims to enhance the treatment options available for central nervous system diseases.
Career Highlights
Throughout his career, Kazuhiro Fukuta has worked with notable companies, including Kringle Pharma Inc. His expertise in the field has allowed him to develop groundbreaking solutions that address critical health issues. His dedication to research and development has positioned him as a key figure in the medical innovation landscape.
Collaborations
Fukuta has collaborated with esteemed colleagues such as Toshikazu Nakamura and Kunio Matsumoto. These partnerships have fostered an environment of innovation and have contributed to the advancement of his research.
Conclusion
Kazuhiro Fukuta's contributions to the field of neurological treatments through his innovative patents highlight his commitment to improving healthcare. His work continues to inspire advancements in medical science and offers hope for better treatment options for patients with neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile